WO2003061557A3 - Levothyroxine pharmaceutical compositions, methods of making and methods of administration - Google Patents
Levothyroxine pharmaceutical compositions, methods of making and methods of administration Download PDFInfo
- Publication number
- WO2003061557A3 WO2003061557A3 PCT/US2002/025854 US0225854W WO03061557A3 WO 2003061557 A3 WO2003061557 A3 WO 2003061557A3 US 0225854 W US0225854 W US 0225854W WO 03061557 A3 WO03061557 A3 WO 03061557A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- making
- pharmaceutical compositions
- administration
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002341555A AU2002341555A1 (en) | 2001-08-14 | 2002-08-14 | Levothyroxine pharmaceutical compositions, methods of making and methods of administration |
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31211401P | 2001-08-14 | 2001-08-14 | |
US31218401P | 2001-08-14 | 2001-08-14 | |
US31228701P | 2001-08-14 | 2001-08-14 | |
US31248301P | 2001-08-14 | 2001-08-14 | |
US31227301P | 2001-08-14 | 2001-08-14 | |
US31211301P | 2001-08-14 | 2001-08-14 | |
US60/312,114 | 2001-08-14 | ||
US60/312,113 | 2001-08-14 | ||
US60/312,184 | 2001-08-14 | ||
US60/312,273 | 2001-08-14 | ||
US60/312,287 | 2001-08-14 | ||
US60/312,483 | 2001-08-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003061557A2 WO2003061557A2 (en) | 2003-07-31 |
WO2003061557A3 true WO2003061557A3 (en) | 2003-11-06 |
Family
ID=27617967
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/025854 WO2003061557A2 (en) | 2001-08-14 | 2002-08-14 | Levothyroxine pharmaceutical compositions, methods of making and methods of administration |
PCT/US2002/025752 WO2003028624A2 (en) | 2001-08-14 | 2002-08-14 | Levothyroxine compositions and methods |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/025752 WO2003028624A2 (en) | 2001-08-14 | 2002-08-14 | Levothyroxine compositions and methods |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002341555A1 (en) |
WO (2) | WO2003061557A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6645526B2 (en) | 2001-11-13 | 2003-11-11 | Mylan Pharmaceuticals, Inc. | Storage stable thyroxine active drug formulations and methods for their production |
US20030099699A1 (en) | 2001-11-13 | 2003-05-29 | Hanshew Dwight D. | Storage stable thyroxine active drug formulations and methods for their production |
WO2005051298A2 (en) | 2003-11-19 | 2005-06-09 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing thyromimetics |
CA2606499C (en) | 2005-05-26 | 2017-06-13 | Metabasis Therapeutics, Inc. | Thyromimetics for the treatment of fatty liver diseases |
KR20190104524A (en) | 2016-11-21 | 2019-09-10 | 바이킹 테라퓨틱스 인코포레이티드 | Treatment method of sugar accumulation disease |
KR102600115B1 (en) | 2017-06-05 | 2023-11-09 | 바이킹 테라퓨틱스 인코포레이티드 | Composition for treating fibrosis |
EP3768690A4 (en) | 2018-03-22 | 2021-11-24 | Viking Therapeutics, Inc. | Crystalline forms and methods of producing crystalline forms of a compound |
CA3164402A1 (en) * | 2020-01-13 | 2021-07-22 | Jaydeep VAGHASHIYA | Sustained release compositions comprising liothyronine |
US11964048B2 (en) | 2020-12-18 | 2024-04-23 | Amneal Complex Products Research Llc | Sustained release compositions comprising liothyronine |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5753254A (en) * | 1994-02-01 | 1998-05-19 | Knoll Aktiengesellschaft | Therapeutic agents containing thyroid hormones |
US5955105A (en) * | 1995-11-14 | 1999-09-21 | Knoll Pharmaceutical Company | Stabilized thyroid hormone preparations and methods of making same |
US6190696B1 (en) * | 1998-06-08 | 2001-02-20 | Pieter J. Groenewoud | Stabilized thyroxine medications |
-
2002
- 2002-08-14 WO PCT/US2002/025854 patent/WO2003061557A2/en not_active Application Discontinuation
- 2002-08-14 AU AU2002341555A patent/AU2002341555A1/en not_active Abandoned
- 2002-08-14 WO PCT/US2002/025752 patent/WO2003028624A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5753254A (en) * | 1994-02-01 | 1998-05-19 | Knoll Aktiengesellschaft | Therapeutic agents containing thyroid hormones |
US5955105A (en) * | 1995-11-14 | 1999-09-21 | Knoll Pharmaceutical Company | Stabilized thyroid hormone preparations and methods of making same |
US6190696B1 (en) * | 1998-06-08 | 2001-02-20 | Pieter J. Groenewoud | Stabilized thyroxine medications |
Also Published As
Publication number | Publication date |
---|---|
AU2002341555A1 (en) | 2003-09-02 |
WO2003028624A2 (en) | 2003-04-10 |
WO2003061557A2 (en) | 2003-07-31 |
WO2003028624A3 (en) | 2003-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1096034A1 (en) | A solid dosage form comprising a fibrate | |
BR0003158A (en) | Instant melting oral dosage formulation | |
TW200505498A (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
BG66093B1 (en) | Controlled release compositions comprising nimesulide | |
MY151468A (en) | Controlled release solid preparation | |
WO2002074247A8 (en) | Pharmaceutical formulations for sustained release | |
MX2009003030A (en) | Galenic form for the trans-mucosal delivery of active ingredients. | |
AU2002231654A1 (en) | Pharmaceutical paste comprising an acid-labile active ingredient | |
EE03089B1 (en) | Effervescent formulation containing ibuprofen and method for its preparation | |
AP2003002763A0 (en) | Controlled release formulations for oral administration | |
MX2010004556A (en) | Pharmaceutical formulation of clavulanic acid. | |
WO2003061557A3 (en) | Levothyroxine pharmaceutical compositions, methods of making and methods of administration | |
IL150528A0 (en) | Ibuprofen containing active agent preparation | |
MXPA03002807A (en) | Stabilization of solid drug formulations. | |
MXPA06000332A (en) | Novel solid pharmaceutical composition comprising amisulpride. | |
WO2002015933A3 (en) | Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser | |
CY1107295T1 (en) | STABILIZATION OF SOLID FORMULON MEDICATIONS FOR THYROID | |
BR0209155A (en) | Pharmaceutical tablet having a high api content | |
WO2003013441A3 (en) | Levothyroxine compositions and methods | |
WO2004014318A3 (en) | Levothyroxine compositions and methods | |
MXPA05008843A (en) | Therapeutic system comprising amoxicillin and clavulanic acid. | |
WO1999047172A3 (en) | Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes | |
ES2171110A1 (en) | Pharmaceutical composition based on ibuprofen and a procedure for the preparation thereof | |
MXPA03007332A (en) | Levothyroxine compositions and methods. | |
AU2001289762A1 (en) | Pharmaceutical extemporary compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |